National Pressure Injury Advisory Panel (NPIAP)
Info-graphic that provides images and general tips positioning to preventing pressure injury when proning patients in acute respiratory distress (including COVID-19).
Category: Pandemic / COVID / Public Health Emergency
2023 National Healthcare Safety Network (NHSN); Patient Safety Component Manual
CDC, National Healthcare Safety Network (NHSN)
The Patient Safety Component includes five modules that focus on events associated with medical devices, surgical procedures, antimicrobial agents used during healthcare, multidrug resistant organisms, and Coronavirus Infectious Disease 2019 (COVID-19).
Unavoidable Pressure Injury during COVID-19 Pandemic: A Position Paper from the National Pressure Injury Advisory Panel
National Pressure Injury Advisory Panel (NPIAP)
The purposes of this National Pressure Injury Advisory Panel (NPIAP) Position Paper are to:
- Summarize the current NPIAP position regarding unavoidable pressure injuries.
- Examine the effects of the COVID-19 crisis on the scope of what is considered an unavoidable pressure injury.
- State the position of the NPIAP regarding determinations of unavoidable pressure injuries during the COVID-19 crisis.
- Renew the NPIAP call to collaborate on the development of criteria for the determination of unavoidable pressure injuries in acute care.
Skin Manifestations with COVID-19
National Pressure Injury Advisory Panel (NPAIP)
Many reports are occurring concerning areas of purpuric/purple skin and purple toe lesions in patients diagnosed with COVID-19 (SARS-CoV-2). Wound care providers are being asked if these skin lesions are forms of Deep Tissue Pressure Injury and/or “skin failure”. Early reports of COVID-19 related
skin changes included rashes, acral areas of erythema with vesicles or pustules (pseudo-chilblain), other vesicular eruptions, urticarial lesions, maculopapular eruptions, and livedo or necrosis. The pattern and presentation of skin manifestations with COVID-19 is more than rashes. The purpose of this paper is to guide the wound care clinician in determining if the “purple skin” being seen is a deep tissue pressure injury or a cutaneous manifestation of COVID-19.
Building Vaccine Confidence in Health Systems and Clinics
Centers for Disease Control (CDC)
Presentation Overview:
- COVID-19 vaccines
- mRNA technology
- Vaccine safety monitoring
- Elements of vaccine confidence
- Strategies for building vaccine confidence in your facility or system
STRIVE Infection Control Training
Centers for Disease Control (CDC)
The CDC/STRIVE curriculum was developed by national infection prevention experts led by the Health Research & Educational Trust (HRET) for CDC. Courses address both the technical and foundational elements of healthcare-associated infection (HAI) prevention. Courses can be taken in any order. Each course has 1 or more modules. Individual modules can be used for; new employee training, annual infection prevention training, and/or periodic training.
Vaccine Storage and Handling Toolkit (Updated Addendum added April 12, 2022 )
Centers for Disease Control (CDC)
This toolkit addresses proper storage, handling, transport,
and emergency handling of COVID-19 vaccines.
The addendum has been updated to clarify COVID-19 vaccination provider requirements, include language related to FDA
authorization and approval of COVID-19 vaccine products, and storage and handling information on Pfzer-BioNTech Vaccine.
COVID-19 Vaccine Training Modules
Centers for Disease Control (CDC)
 | COVID-19 Vaccine Training: General Overview of Immunization Best Practices for Healthcare Providers (Updated October 27. 2021) |
 | Janssen COVID-19 Vaccine (Johnson & Johnson):What Healthcare Professionals Need to Know (Updated March 8. 2022) |
 | Moderna COVID-19 Vaccine: What Healthcare Professionals Need to Know (Updated November 3. 2022) |
 | Pfizer-BioNTech COVID-19 Vaccine: What Healthcare Professionals Need to Know (Updated November 3. 2022) |
| Novavax COVID-19 Vaccine: What Healthcare Professionals Need to Know (Updated December 5. 2022) |